IF MM turns his idea into a 500 - 1BN revenue empire...... as a 17% shareholder, I guess he should be entitled to pay himself 17% right
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling